ECIFX
Price
$13.05
Change
+$0.01 (+0.08%)
Updated
Dec 3 closing price
Net Assets
1.1B
RLBGX
Price
$39.90
Change
+$0.11 (+0.28%)
Updated
Dec 3 closing price
Net Assets
269.37B
Interact to see
Advertisement

ECIFX vs RLBGX

Header iconECIFX vs RLBGX Comparison
Open Charts ECIFX vs RLBGXBanner chart's image
Eaton Vance Balanced C
Price$13.05
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets1.1B
American Funds American Balanced R6
Price$39.90
Change+$0.11 (+0.28%)
VolumeN/A
Net Assets269.37B
ECIFX vs RLBGX Comparison Chart in %
View a ticker or compare two or three
VS
ECIFX vs. RLBGX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECIFX is a StrongBuy and RLBGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 269B vs. ECIFX (1.1B). RLBGX pays higher dividends than ECIFX: RLBGX (1.98) vs ECIFX (0.43). ECIFX was incepted earlier than RLBGX: ECIFX (32 years) vs RLBGX (17 years). ECIFX (1.72) is less costly to investors than RLBGX (0.25). RLBGX is a more actively managed with annual turnover of: 44.00 vs. ECIFX (5.00). RLBGX has a lower initial minimum investment than ECIFX: RLBGX (250) vs ECIFX (1000). RLBGX annual gain was more profitable for investors over the last year : 9.66 vs. ECIFX (3.50). RLBGX return over 5 years is better than : 41.12 vs. ECIFX (23.05).
ECIFXRLBGXECIFX / RLBGX
Total Expense Ratio1.720.25688%
Annual Report Gross Expense Ratio1.720.25688%
Fund Existence32 years17 years-
Gain YTD10.27316.95361%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B269B0%
Annual Yield % from dividends0.431.9822%
Returns for 1 year3.509.6636%
Returns for 3 years32.2341.5877%
Returns for 5 years23.0541.1256%
Returns for 10 years60.2378.2477%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX82.321.55
+1.92%
Inhibrx Biosciences Inc.
BMO125.741.57
+1.26%
Bank of Montreal
LIVE9.81-0.04
-0.41%
Live Ventures
PIPR323.49-5.45
-1.66%
Piper Sandler Companies
ARMP5.53-1.23
-18.24%
Armata Pharmaceuticals